We aimed to delineate cardiopulmonary interactions in acute bronchiolitis and to evaluate the capacity of a combined cardiopulmonary ultrasonography to predict the need for respiratory support. This was a prospective observational single-center study that includes infants <12 month of age admitted to a hospital due to acute bronchiolitis. All the included patients underwent clinical, laboratory and cardiopulmonary ultrasonographic evaluation at the same time point within 24 h of hospital admission. The existence of significant correlation between cardiac and respiratory parameters was the primary outcome. The association of different cardiopulmonary variables with the need of respiratory support higher than O2, the length of stay hospitalization, the PICU stay and the duration of respiratory support were a secondary outcome. We enrolled 112 infants (median age 1 (0.5–3) months; 62% males) hospitalized with acute bronchiolitis. Increased values of the pulmonary variables (BROSJOD score, pCO2 and LUS) showed moderate correlations with NT-proBNP and all echocardiographic parameters indicative of pulmonary hypertension and myocardial dysfunction (Tei index). Up to 36 (32%) infants required respiratory support during the hospitalization. This group presented with higher lung ultrasound score (p < 0.001) and increased values of NT-proBNP (p < 0.001), the Tei index (p < 0.001) and pulmonary artery pressures (p < 0.001). All the analyzed respiratory and cardiac variables showed moderate-to-strong correlations with the LOS of hospitalization and the time of respiratory support. Lung ultrasound and echocardiography showed a moderate-to-strong predictive accuracy for the need of respiratory support in the ROC analysis, with the AUC varying from 0.74 to 0.87. Those cases of bronchiolitis with a worse pulmonary status presented with a more impaired cardiac status. Cardiopulmonary ultrasonography could be a useful tool to easily identify high-risk populations for complicated acute bronchiolitis hospitalization.
Objective: To evaluate if hypoalbuminemia on admission predict disease severity in children with acute bronchiolitis (AB). Working hypothesis: Hypoalbuminemia is associated with worse outcome in infants with AB. Study design: Single-centre prospective cohort study. Patient-subject selection: Infants aged <12 month-old with AB. Methodology: Serum albumin levels were determined within the first 24 hours upon inclusion. The primary outcome was the need of pediatric intensive care unit (PICU) admission. Results: We enrolled 90 cases of AB. Serum albumin was independently associated with C-Reactive protein levels (CRP) (rs=-0,28; p=0.002). Fourteen (15.5%) cases required PICU admission. They presented lower serum albumin levels (3.7 (0.11) vs 4 (0.5) g/dl; p=0.034) regarding those patients without severe illness. In the multivariate logistic regression analysis, hypoalbuminemia was independently associated with a higher risk of severe illness (adjusted Odds Ratio 4.1 (1.2-85); p=0.032). The area under the ROC curve for serum albumin to predict adverse outcome was 0.70 (95% Confidence interval of 0.59-0.79). A cut-off point of 3.5 g/dl presented a sensitivity of 0.71, specificity of 0.68, positive predictive value of 0.29, and negative predictive value of 0.92. Conclusion: Low serum albumin levels at admission are significantly associated with higher PICU admission rates in infants with AB. The inflammatory response could play a key role in the occurrence of hypoalbuminemia in AB.
Background: Serum ferritin levels, biomarkers that seem to be associated with disease severity in adults with coronavirus disease 2019 (COVID-19) infection, are unknown in acute bronchiolitis (AB). Our objective is to explore the serum ferritin levels in a sample of infants with AB and to see if they are correlated with severity. Methods: This was a secondary analysis of an ongoing single-centre prospective cohort study including infants aged < 12 months-old with AB between 2018 and 2019. All patients underwent clinical, laboratory, and microbiologic evaluations. The blood collection was drawn, and an aliquot was frozen at -80ºC, within the first 24 hours after admission. For this work, those samples have been thawed, and a ferritin analysis has been performed. Biochemical data were recorded. The primary outcome was to determine the value of serum ferritin in patients with AB according to the severity groups. Findings: We analysed 102 congealed samples of patients with AB. The median age was 1 (0-2) month, and there were 62 (59%) males in the sample. A total of 16 (15.2%) cases presented with a known comorbidity associated with the development of a severe disease. The median value of serum ferritin was 236 ng/ml (IQR: 131-367). There was no statistical difference between the median value of serum ferritin in the severe group (26 patients) and non-severe group (76 patients) (274 ng/ml (IQR: 185-469) vs 230 ng/ml (IQR: 102-340), p= 0.495). Interpretation: Ferritin levels are not associated with disease severity in AB. Although they are not useful as biomarkers for severity in AB, the absence of elevated ferritin levels observed in our cohort suggest a potential role to differentiate severe bronchiolitis from other severe respiratory diseases, such as COVID-19. Funding: The work has not been funded by any source. Declaration of Interest: None of the authors in this manuscript has any conflict of interest to declare. Ethical Approval: The study was approved by the Institutional Review Board of the local ethical investigation committee. Written informed consent was obtained.